Table 2. Demographic key outcomes variables.
| Low-income Pensioners (Intervention 1) | Low-income working population (Control) | Middle-income working population (Intervention 2) | ||||
|---|---|---|---|---|---|---|
| % of individuals | ||||||
| 19.5 (7,898) | 63.2 (25,588) | 17.3 (6,985) | ||||
| Age average of individuals within each group | ||||||
| 64 | 32 | 34 | ||||
| % of individuals within each group by sex | ||||||
| Women | Men | Women | Men | Women | Men | |
| 58.4 | 41.5 | 52.6 | 47.4 | 49.0 | 51.0 | |
| Income average of individuals within each group | ||||||
| 8889 | 8880 | 52094 | ||||
| % of individuals per island | ||||||
| Fuerteventura | 10.8 | 71.9 | 17.3 | |||
| Gran Canaria | 22.9 | 59.6 | 17.49 | |||
| La Gomera | 21.9 | 61.3 | 16.8 | |||
| El Hierro | 23.0 | 60.0 | 17.1 | |||
| Lanzarote | 12.9 | 69.9 | 17.2 | |||
| La Palma | 23.2 | 60.3 | 16.5 | |||
| Tenerife | 18.4 | 64.4 | 17.2 | |||
| % of individuals within each group that have obtained medicines at any time during the studied period | ||||||
| Cardiovascular agents | 49.9 | 7.3 | 9.8 | |||
| Antihyperlipidemics | 31.0 | 4.1 | 5.5 | |||
| Endocrine/metabolic agents | 44.2 | 6.2 | 7.0 | |||
| Central nervous system agents | 39.0 | 7.7 | 7.8 | |||
| Biological* | 0.4 | 0.2 | 0.3 | |||
| Diabetes drugs | 17.7 | 2.3 | 3.0 | |||
| Dermatological | 6.7 | 2.0 | 1.84 | |||
| Gastrointestinal drugs | 4.57 | 1.0 | 0.9 | |||
| Analgesics/anti-inflammatories | 33.6 | 8.4 | 7.4 | |||
| Eye, ear, nose and throat preparations | 9.0 | 0.7 | 1.0 | |||
| Anti-infective | 7.3 | 5.6 | 5.2 | |||
| Immunological agents* | 0.0 | 0.0 | 0.1 | |||
| Upper respiratory agents | 1.7 | 1.0 | 1.2 | |||
| Genitourinary agents | 9.3 | 1.8 | 1.9 | |||
| Pulmonary drugs | 11.8 | 5.2 | 5.1 | |||
| % of individuals who have been dispensed medicines from two or more therapeutic groups | ||||||
| 54.05 (4,562) | 35.61 (3,006) | 10.34 (873) | ||||
| % of individuals who have been dispensed medicines from one therapeutic group | ||||||
| 10.42 (3,336) | 70.50 (22,582) | 19.08 (6,112) | ||||
| Number of individuals that changed their contribution code after the reform | ||||||
| To: | Low-income pensioners (TSI 002) | Low-income working population (TSI 003) | Middle-income working population (TSI 004) | |||
|
From: |
Low-income pensioners (TSI 002) | - | (350) | (9) | ||
| Low-income working population (TSI 003) | (383) | - | (938) | |||
| Middle-income working population (TSI 004) | (136) | (1,070) | - | |||
The number of individuals is shown in parentheses.
*Biological and immunological agents have been removed from the sample because the number of individuals in each of these groups is not enough.
The therapeutic groups are sorted by price-elasticity (at the top the most inelastic, while at the bottom the most elastic).